Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial

Alice T. Shaw, Leena Gandhi, Shirish Gadgeel, Gregory J. Riely, Jeremy Cetnar, Howard West, D. R. Camidge, Mark A. Socinski, Alberto Chiappori, Tarek Mekhail, Bo H. Chao, Hossein Borghaei, Kathryn A. Gold, Ali Zeaiter, Walter Bordogna, Bogdana Balas, Oscar Puig, Volkmar Henschel, Sai Hong Ignatius Ou

Research output: Contribution to journalArticlepeer-review

501 Scopus citations

Fingerprint

Dive into the research topics of 'Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences